Conference
Sorafenib As Maintenance Therapy Post Allogeneic Stem Cell Transplantation for FLT3-ITD Positive AML: Results from the Randomized, Double-Blind, Placebo-Controlled Multicentre Sormain Trial
Abstract
Abstract
Authors
Burchert A; Bug G; Finke J; Stelljes M; Rollig C; Wäsch R; Bornhäuser M; Berg T; Lang F; Ehninger G
Volume
132
Publisher
American Society of Hematology
Publication Date
November 29, 2018
DOI
10.1182/blood-2018-99-112614
Conference proceedings
Blood
Issue
Supplement 1
ISSN
0006-4971